Skip to content

Effect of Plantago on the of pulmonary complications of radiation therapy

The effect of Plantago on the prevention of pulmonary complications of radiation therapy in patients with breast cancer

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180617040114N2
Enrollment
60
Registered
2019-11-09
Start date
2019-10-11
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: This group includes 30 patients with breast cancer who are candidates for radiotherapy. This group receives the Plantago syrup for three months with treatment. Int

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 65 Years

Inclusion criteria

Inclusion criteria: Breast Cancer and Candidate Radiation Therapy Ages between 17 and 65 years Life expectancy of more than one year based on estimates of physician or medical team Physical and mental ability to cooperate in filling out the questionnaire

Exclusion criteria

Exclusion criteria: People with liver and kidney disease. People who have a history of allergy to herbal medicines.

Design outcomes

Primary

MeasureTime frame
Forced Vital Capacity (FVC). Timepoint: Before intervention and three months after intervention. Method of measurement: Spirometry.;Forced Expiratory Volume in the second period (FEV1). Timepoint: Before intervention and three months after intervention. Method of measurement: Spirometry.;Forced Vital Capacity (FVC) Ratio to Forced Expiratory Volume in the second period (FEV1). Timepoint: Before intervention and three months after intervention. Method of measurement: Spirometry.

Secondary

MeasureTime frame
Phlegm and mucus in the throat. Timepoint: Before intervention and three months after intervention. Method of measurement: Aspiration.;Score of quality life. Timepoint: Before intervention and three months after intervention. Method of measurement: Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Amir Hossein Latifi

Arak University of Medical Sciences

seiedalatifi@yahoo.com+98 38 4817 6341

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026